Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Nutex Health (NUTX) over the last 15 years, with Q3 2025 value amounting to -$29.9 million.

  • Nutex Health's Cash from Financing Activities fell 700142.52% to -$29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.1 million, marking a year-over-year decrease of 3394285.76%. This contributed to the annual value of $1.1 million for FY2024, which is 14805.63% up from last year.
  • Per Nutex Health's latest filing, its Cash from Financing Activities stood at -$29.9 million for Q3 2025, which was down 700142.52% from -$15.4 million recorded in Q2 2025.
  • Over the past 5 years, Nutex Health's Cash from Financing Activities peaked at $5.7 million during Q1 2024, and registered a low of -$68.9 million during Q2 2021.
  • Its 5-year average for Cash from Financing Activities is -$12.0 million, with a median of -$4.3 million in 2023.
  • Data for Nutex Health's Cash from Financing Activities shows a peak YoY increase of 188402.05% (in 2021) and a maximum YoY decrease of 2378136.52% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Nutex Health's Cash from Financing Activities stood at -$32.8 million in 2021, then surged by 54.99% to -$14.8 million in 2022, then skyrocketed by 73.47% to -$3.9 million in 2023, then rose by 23.71% to -$3.0 million in 2024, then crashed by 901.16% to -$29.9 million in 2025.
  • Its last three reported values are -$29.9 million in Q3 2025, -$15.4 million for Q2 2025, and -$6.8 million during Q1 2025.